Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Loss of Medicare coverage sends Pacific Edge's share prices plummeting over 60%.
Pacific Edge, a New Zealand cancer diagnostics company, saw its share prices drop over 60% after the US Medicare provider, Novitas, decided to stop covering the company's Cxbladder tests starting February 23.
The loss of Medicare coverage, which contributed over half of the company’s revenue, will significantly impact Pacific Edge financially.
The company is considering legal action and other strategies to regain coverage.
5 Articles
La pérdida de cobertura de Medicare hace que los precios de las acciones de Pacific Edge se desplomen en más del 60%.